{"title_page": "Para-Chloromethamphetamine", "text_new": "{{distinguish|para-Chloroamphetamine}}\n{{DISPLAYTITLE:''para''-Chloromethamphetamine}}\n{{Drugbox\n| drug_name = ''para''-Chloromethamphetamine\n| IUPAC_name    = 1-(4-Chlorophenyl)-''N''-methylpropan-2-amine\n| image         = 4-CMA structure.png\n| width         = 220\n\n<!--Clinical data-->\n| tradename                =\n| routes_of_administration =\n| legal_status = \n| legal_DE = NpSG\n| legal_UK = Class B\n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 30572-91-9\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = IXP5G5WMYA\n| ATC_suffix     =\n| PubChem        = 3128\n| ChemSpiderID = 3016\n\n<!--Chemical data-->\n| C=10 | H=14 | Cl=1 | N=1\n| smiles = ClC1=CC=C(C=C1)CC(C)NC\n| StdInChI = 1S/C10H14ClN/c1-8(12-2)7-9-3-5-10(11)6-4-9/h3-6,8,12H,7H2,1-2H3\n| StdInChIKey = XXLWNLKEOWWHDC-UHFFFAOYSA-N\n}}\n\n'''''para''-Chloromethamphetamine''' (also known as '''4-chloromethamphetamine''' and '''4-CMA''') is a [[stimulant]] that is the ''N''-methyl derivative and prodrug of the neurotoxic drug [[Para-Chloroamphetamine|''para''-chloroamphetamine]] (4-CA).<ref>{{cite journal | title=[<sup>3</sup>H]Monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetaimne and p-chloroamphetamine analogues |vauthors=Johnson MP, Conarty PF, Nichols DE | journal=European Journal of Pharmacology |date=July 1991  | volume=200 | issue=1 | pages=9\u201316 | doi=10.1016/0014-2999(91)90659-E | pmid=1685125}}</ref><ref>{{cite journal | title=Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: Drug levels in brain and effects on brain serotonin metabolism |author1=R.W. Fuller |author2=J.C. Baker |author3=K.W. Perry |author4=B.B. Molloy | journal=Neuropharmacology |date=October 1975  | volume=14 | issue=10 | pages=739\u2013746 | doi=10.1016/0028-3908(75)90099-4 | pmid=1196472}}</ref> It has been found to decrease [[serotonin]] in rats.<ref>{{cite journal | title=Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: Correlations between behavior and neurochemistry |author1=Kevin Sean Murnane |author2=Shane Alan Perrine |author3=Brendan James Finton |author4=Matthew Peter Galloway |author5=Leonard Lee Howell |author6=William Edward Fantegrossi | journal=Psychopharmacology |date=April 2012  | volume=220 | issue=3 | pages=495\u2013508 | doi=10.1007/s00213-011-2504-0 | pmid=21993877 | pmc=3289749}}</ref><ref>{{cite journal | title=Decrease of cerebral 5-hydroxytryptamine and 5-hydroxyindolacetic acid by an arylalkylamine |author1=A. Pletscher |author2=W.P. Burkard |author3=H. Bruderer |author4=K.F. Gey | journal=Life Sciences |date=November 1963  | volume=2 | issue=11 | pages=828\u2013833 | doi=10.1016/0024-3205(63)90094-8|pmid=14078137 }}</ref><ref>{{cite journal | title=Lowering of brain serotonin level by chloramphetamines |author1=Ray W. Fuller |author2=C.W. Hines |author3=J. Mills | journal=Biochemical Pharmacology |date=April 1965  | volume=14 | issue=4 | pages=483\u2013488 | doi=10.1016/0006-2952(65)90221-2 | pmid=14322972}}</ref> Further investigation into the long-term effects of chloroamphetamines discovered that administration of 4-CMA caused a prolonged reduction in the levels of [[serotonin]] and the activity of [[tryptophan hydroxylase]] in the brain one month after injection of a single dose of the drug.<ref>{{cite journal | url=http://jpet.aspetjournals.org/content/192/1/33.short | title=Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms. |author1=E Sanders-Bush |author2=J A Bushing |author3=F Sulser  |last-author-amp=yes | journal=Journal of Pharmacology and Experimental Therapeutics |date=January 1975  | volume=192 | issue=1 | pages=33\u201341 | pmid=1123726}}</ref>\n\nAnother study on rats found that 4-chloromethamphetamine was more potent at inducing conditioned taste aversion than [[methamphetamine]].<ref>{{cite journal | title=Comparative potencies of amphetamine, fenfluramine and related compounds in taste aversion experiments in rats |author1=D.A. Booth |author2=C.W.T. Pilcher |author3=G.D. D'Mello |author4=I.P. Stolerman | journal=British Journal of Pharmacology |date=December 1977  | volume=61 | issue=4 | pages=669\u2013677 | doi=10.1111/j.1476-5381.1977.tb07560.x | pmid=597669 | pmc=1668069}}</ref>\n\n4-Chloromethamphetamine was further investigated in the 1960s along with 4-CA and it was noted that they differed from their parent [[amphetamine]] and methamphetamine substances by exhibiting only a slight central stimulant effect in both animals and humans and that they acted like [[antidepressant]]s rather than stimulants.<ref>{{cite journal | title=Influencing the human indoleamine metabolism by means of a chlorinated amphetamine derivative with antidepressive action (p-Chloro-N-Methylamphetamine) |author1=H. M. van Praagtory |author2=J. Korf |author3=F. van Woudenberg |author4=T. P. Kits | journal=Psychopharmacologia |date=July 1968  | volume=13 | issue=2 | pages=145\u2013160 | doi=10.1007/BF00404812|pmid=5678577 }}</ref><ref>{{cite journal | title=A controlled study of the antidepressant effect of p-Chloro-N-methylamphetamine, a compound with a selective effect on the central 5-hydroxytryptamine metabolism. |vauthors=Kits TP, van Praag HM | journal=Acta Psychiatrica Scandinavica | year=1970 | volume=46 | issue=4 | pages=365\u2013373 | doi=10.1111/j.1600-0447.1970.tb02126.x | pmid=5502782}}</ref><ref>{{cite journal | title=Investigation into the possible influence of chlorinated amphetamine derivatives on 5-hydroxytryptamine synthesis in man |author1=H. M. van Praag |author2=J. Korf |author3=F. van Woudenberg | journal=Psychopharmacologia |date=December 1970  | volume=18 | issue=4 | pages=412\u2013420 | doi=10.1007/BF00402767 | pmid=4923523}}</ref><ref>{{cite journal | title=A comparative study of the therapeutic effects of some 4-chlorinated amphetamine derivatives in depressive patients |author1=H. M. van Praag |author2=T. Schut |author3=E. Bosma |author4=R. van den Bergh | journal=Psychopharmacologia |date=March 1971  | volume=20 | issue=1 | pages=66\u201376 | doi=10.1007/BF00404060 | pmid=5565748}}</ref>\n[[File:Tablet containing 4-chloromethamphetamine.jpg|frame|Tablet containing 4-chloromethamphetamine, found in 2015 in Belgium.]]\n4-Chloromethamphetamine was identified outside of the laboratory for the first time at the Tomorrowland festival edition 2015, where a tablet was found in possession of a drug dealer (see picture).<ref>{{Cite journal|date=2018-07-01|title=Identification and characterization of 4-chloromethamphetamine (4-CMA) in seized ecstacy \u2014 a risk to public health|journal=Forensic Science International|language=en|volume=288|pages=173\u2013180|doi=10.1016/j.forsciint.2018.04.023|pmid=29753935|issn=0379-0738|last1=Blanckaert|first1=Peter|last2=Vanquekelberghe|first2=Stijn|last3=Coopman|first3=Vera|last4=Risseeuw|first4=Martijn D.P.|last5=Van Calenbergh|first5=Serge|last6=Cordonnier|first6=Jan|hdl=1854/LU-8569680}}</ref>\n\n== See also ==\n* [[3-Chloromethamphetamine]]\n* [[Para-Bromoamphetamine|4-Bromoamphetamine]]\n* [[4-Fluoroamphetamine]]\n* [[4-Fluoromethamphetamine]]\n* [[Para-Iodoamphetamine|4-Iodoamphetamine]]\n\n== References ==\n{{Reflist}}\n\n{{Stimulants}}\n\n{{DEFAULTSORT:Chloromethamphetamine, para-}}\n[[Category:Chloroarenes]]\n[[Category:Designer drugs]]\n[[Category:Stimulants]]\n[[Category:Methamphetamines]]\n[[Category:Neurotoxins]]\n[[Category:Serotonin-norepinephrine-dopamine releasing agents]]\n", "text_old": "{{distinguish|para-Chloroamphetamine}}\n{{DISPLAYTITLE:''para''-Chloromethamphetamine}}\n{{Drugbox\n| drug_name = ''para''-Chloromethamphetamine\n| IUPAC_name    = 1-(4-Chlorophenyl)-''N''-methylpropan-2-amine\n| image         = 4-CMA structure.png\n| width         = 220\n\n<!--Clinical data-->\n| tradename                =\n| routes_of_administration =\n| legal_status = \n| legal_DE = NpSG\n| legal_UK = Class B\n\n<!--Identifiers-->\n| CAS_number_Ref = {{cascite|correct|??}}\n| CAS_number = 30572-91-9\n| ATC_suffix     =\n| PubChem        = 3128\n| ChemSpiderID = 3016\n\n<!--Chemical data-->\n| C=10 | H=14 | Cl=1 | N=1\n| smiles = ClC1=CC=C(C=C1)CC(C)NC\n| StdInChI = 1S/C10H14ClN/c1-8(12-2)7-9-3-5-10(11)6-4-9/h3-6,8,12H,7H2,1-2H3\n| StdInChIKey = XXLWNLKEOWWHDC-UHFFFAOYSA-N\n}}\n\n'''''para''-Chloromethamphetamine''' (also known as '''4-chloromethamphetamine''' and '''4-CMA''') is a [[stimulant]] that is the ''N''-methyl derivative and prodrug of the neurotoxic drug [[Para-Chloroamphetamine|''para''-chloroamphetamine]] (4-CA).<ref>{{cite journal | title=[<sup>3</sup>H]Monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetaimne and p-chloroamphetamine analogues |vauthors=Johnson MP, Conarty PF, Nichols DE | journal=European Journal of Pharmacology |date=July 1991  | volume=200 | issue=1 | pages=9\u201316 | doi=10.1016/0014-2999(91)90659-E | pmid=1685125}}</ref><ref>{{cite journal | title=Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: Drug levels in brain and effects on brain serotonin metabolism |author1=R.W. Fuller |author2=J.C. Baker |author3=K.W. Perry |author4=B.B. Molloy | journal=Neuropharmacology |date=October 1975  | volume=14 | issue=10 | pages=739\u2013746 | doi=10.1016/0028-3908(75)90099-4 | pmid=1196472}}</ref> It has been found to decrease [[serotonin]] in rats.<ref>{{cite journal | title=Effects of exposure to amphetamine derivatives on passive avoidance performance and the central levels of monoamines and their metabolites in mice: Correlations between behavior and neurochemistry |author1=Kevin Sean Murnane |author2=Shane Alan Perrine |author3=Brendan James Finton |author4=Matthew Peter Galloway |author5=Leonard Lee Howell |author6=William Edward Fantegrossi | journal=Psychopharmacology |date=April 2012  | volume=220 | issue=3 | pages=495\u2013508 | doi=10.1007/s00213-011-2504-0 | pmid=21993877 | pmc=3289749}}</ref><ref>{{cite journal | title=Decrease of cerebral 5-hydroxytryptamine and 5-hydroxyindolacetic acid by an arylalkylamine |author1=A. Pletscher |author2=W.P. Burkard |author3=H. Bruderer |author4=K.F. Gey | journal=Life Sciences |date=November 1963  | volume=2 | issue=11 | pages=828\u2013833 | doi=10.1016/0024-3205(63)90094-8|pmid=14078137 }}</ref><ref>{{cite journal | title=Lowering of brain serotonin level by chloramphetamines |author1=Ray W. Fuller |author2=C.W. Hines |author3=J. Mills | journal=Biochemical Pharmacology |date=April 1965  | volume=14 | issue=4 | pages=483\u2013488 | doi=10.1016/0006-2952(65)90221-2 | pmid=14322972}}</ref> Further investigation into the long-term effects of chloroamphetamines discovered that administration of 4-CMA caused a prolonged reduction in the levels of [[serotonin]] and the activity of [[tryptophan hydroxylase]] in the brain one month after injection of a single dose of the drug.<ref>{{cite journal | url=http://jpet.aspetjournals.org/content/192/1/33.short | title=Long-term effects of p-chloroamphetamine and related drugs on central serotonergic mechanisms. |author1=E Sanders-Bush |author2=J A Bushing |author3=F Sulser  |last-author-amp=yes | journal=Journal of Pharmacology and Experimental Therapeutics |date=January 1975  | volume=192 | issue=1 | pages=33\u201341 | pmid=1123726}}</ref>\n\nAnother study on rats found that 4-chloromethamphetamine was more potent at inducing conditioned taste aversion than [[methamphetamine]].<ref>{{cite journal | title=Comparative potencies of amphetamine, fenfluramine and related compounds in taste aversion experiments in rats |author1=D.A. Booth |author2=C.W.T. Pilcher |author3=G.D. D'Mello |author4=I.P. Stolerman | journal=British Journal of Pharmacology |date=December 1977  | volume=61 | issue=4 | pages=669\u2013677 | doi=10.1111/j.1476-5381.1977.tb07560.x | pmid=597669 | pmc=1668069}}</ref>\n\n4-Chloromethamphetamine was further investigated in the 1960s along with 4-CA and it was noted that they differed from their parent [[amphetamine]] and methamphetamine substances by exhibiting only a slight central stimulant effect in both animals and humans and that they acted like [[antidepressant]]s rather than stimulants.<ref>{{cite journal | title=Influencing the human indoleamine metabolism by means of a chlorinated amphetamine derivative with antidepressive action (p-Chloro-N-Methylamphetamine) |author1=H. M. van Praagtory |author2=J. Korf |author3=F. van Woudenberg |author4=T. P. Kits | journal=Psychopharmacologia |date=July 1968  | volume=13 | issue=2 | pages=145\u2013160 | doi=10.1007/BF00404812|pmid=5678577 }}</ref><ref>{{cite journal | title=A controlled study of the antidepressant effect of p-Chloro-N-methylamphetamine, a compound with a selective effect on the central 5-hydroxytryptamine metabolism. |vauthors=Kits TP, van Praag HM | journal=Acta Psychiatrica Scandinavica | year=1970 | volume=46 | issue=4 | pages=365\u2013373 | doi=10.1111/j.1600-0447.1970.tb02126.x | pmid=5502782}}</ref><ref>{{cite journal | title=Investigation into the possible influence of chlorinated amphetamine derivatives on 5-hydroxytryptamine synthesis in man |author1=H. M. van Praag |author2=J. Korf |author3=F. van Woudenberg | journal=Psychopharmacologia |date=December 1970  | volume=18 | issue=4 | pages=412\u2013420 | doi=10.1007/BF00402767 | pmid=4923523}}</ref><ref>{{cite journal | title=A comparative study of the therapeutic effects of some 4-chlorinated amphetamine derivatives in depressive patients |author1=H. M. van Praag |author2=T. Schut |author3=E. Bosma |author4=R. van den Bergh | journal=Psychopharmacologia |date=March 1971  | volume=20 | issue=1 | pages=66\u201376 | doi=10.1007/BF00404060 | pmid=5565748}}</ref>\n[[File:Tablet containing 4-chloromethamphetamine.jpg|frame|Tablet containing 4-chloromethamphetamine, found in 2015 in Belgium.]]\n4-Chloromethamphetamine was identified outside of the laboratory for the first time at the Tomorrowland festival edition 2015, where a tablet was found in possession of a drug dealer (see picture).<ref>{{Cite journal|date=2018-07-01|title=Identification and characterization of 4-chloromethamphetamine (4-CMA) in seized ecstacy \u2014 a risk to public health|journal=Forensic Science International|language=en|volume=288|pages=173\u2013180|doi=10.1016/j.forsciint.2018.04.023|pmid=29753935|issn=0379-0738|last1=Blanckaert|first1=Peter|last2=Vanquekelberghe|first2=Stijn|last3=Coopman|first3=Vera|last4=Risseeuw|first4=Martijn D.P.|last5=Van Calenbergh|first5=Serge|last6=Cordonnier|first6=Jan|hdl=1854/LU-8569680}}</ref>\n\n== See also ==\n* [[3-Chloromethamphetamine]]\n* [[Para-Bromoamphetamine|4-Bromoamphetamine]]\n* [[4-Fluoroamphetamine]]\n* [[4-Fluoromethamphetamine]]\n* [[Para-Iodoamphetamine|4-Iodoamphetamine]]\n\n== References ==\n{{Reflist}}\n\n{{Stimulants}}\n\n{{DEFAULTSORT:Chloromethamphetamine, para-}}\n[[Category:Chloroarenes]]\n[[Category:Designer drugs]]\n[[Category:Stimulants]]\n[[Category:Methamphetamines]]\n[[Category:Neurotoxins]]\n[[Category:Serotonin-norepinephrine-dopamine releasing agents]]\n", "name_user": "Fswitzer4", "label": "safe", "comment": "added FDA UNII to drug box", "url_page": "//en.wikipedia.org/wiki/Para-Chloromethamphetamine"}
